Prevention, Detection, and Management of Respiratory Depression Associated with Neuraxial Opioid Administration
Publication Date: March 1, 2016
Last Updated: March 14, 2022
Summary of Recommendations
Identification of Patients at Increased Risk of Respiratory Depression
Conduct a focused history and physical examination before administering neuraxial opioids.
- Direct particular attention toward signs, symptoms, or a history of sleep apnea, co-existing diseases or conditions (e.g., diabetes, obesity), current medications (including preoperative opioids), and adverse effects after opioid administration.
- A physical examination should include, but is not limited to, baseline vital signs, airway, heart, lung, and cognitive function.
6731
Title
Prevention, Detection, and Management of Respiratory Depression Associated with Neuraxial Opioid Administration
Authoring Organization
American Society of Anesthesiologists